What is the current price and trading status of BRN.AX stock?

BRN.AX stock trades pre-market at **A$0.135** on 10 Mar 2026, down **3.57%**, with volume around **6,430,141**. It is listed on the ASX in Australia and shows high short-term volatility.

How does Meyka AI view BRN.AX stock?

Meyka AI rates BRN.AX with a score out of 100: **68.92 (Grade B, HOLD)**. The grade reflects sector comparison, financial growth, key metrics and forecasts. This is informational and not financial advice.

What are the main valuation concerns for BRN.AX stock?

Valuation concerns include a high price-to-sales of **121.83**, price-to-book **6.91**, negative EPS and ongoing cash burn. These metrics indicate the market expects future revenue growth to justify the share price.

What catalysts should investors watch for BRN.AX stock?

Watch Akida commercial shipments, design wins, customer announcements and quarterly updates. Positive revenue or large-scale partnerships would materially change BRN.AX stock outlook and liquidity patterns.

AU Stocks

BRN.AX BrainChip Holdings Ltd ASX pre-market A$0.135 10 Mar 2026: AI outlook faces revenue test

ByHuzaifa Zahoor March 10, 2026

BRN.AX stock opened pre-market at A$0.135, down 3.57%, as investors weigh near-term sales against long-term neuromorphic opportunity. BrainChip Holdings Ltd (BRN.AX) trades on the ASX with market cap A$318,391,868 and daily volume near 6,430,141 shares. The company’s Akida edge AI chips remain a strategic asset, but current trading reflects mixed fundamentals, elevated valuation multiples and a recent pullback versus the 50-day average of A$0.157. We examine technicals, financials and Meyka AI forecasts to frame risk and reward for AI-focused portfolios.